Light-sensitive photoswitches could restore sight to those with macular degeneration
A research center newly created by the University of California, Berkeley, and Lawrence Berkeley National Laboratory (LBNL) aims to put light-sensitive switches in the body's cells that can be flipped on and off as easily as a remote control operates a TV. Optical switches like these could trigger a chemical reaction, initiate a muscle contraction, activate a drug or stimulate a nerve cell...Purification of the Components of Human Macular Carotenoid-Binding Complex, Rev A
The macular region of the human retina is responsible for almost all color vision and most of the high resolution visual acuity. This part of the retina, known as the macula lutea, or yellow spot, accumulates approximately 200 ng of two closely-related compounds, lutein and zeaxanthin....Fast screening for macular degeneration
According to a new study, researchers are investigating a new technique for mapping the back of the retina and screening for the onset of blindness. Age-related macular degeneration (AMD) is the leading cause of blindness in older people. //A team at the University of Utah now report on a technical advance that could be developed into a rapid screen for AMD among people at risk.They could then be...Gene treatment for macular degeneration
As researchers learn more and more about the genes that cause a number of medical conditions, opportunities for treatment with gene therapy become increasingly likely. //In an interview with Jonathan Davidorf, M.D., explained exciting new advances in the treatment of some forms of macular degeneration. According to him it is the use of gene therapy to treat some forms of macular degeneration. <br...Laser may stop macular degeneration
All around the United States, researchers at 24 medical centers hope to arbitrate whether a laser can stop the development of macular degeneration before it progresses. There are two forms of macular degeneration, wet and dry. //The dry form makes upto75 percent of all cases and is characterized by the formation of yellowish deposits within the layers of the retina known as drusen. People with dr...Macular Degeneration treatment with Laser
Macular Degeneration is a blinding condition, which currently affects 30 per cent of people over the age of 75. Most people affected with this disease suffer from the dry form that has no proven treatment until now. However, a new laser could offer hope to those suffering from the disease. This laser treatment, which takes just 15 minutes, involves gently heating the retinal pigment// epithelium,...Age-Related Macular Degeneration - Risk Factors
A new study identifies several new risk factors for age-related macular degeneration, a sight-robbing disease mainly seen in older people. As the population ages, more and more people worldwide are showing signs of age-related macular degeneration, or AMD. About 30 percent of people over 70 are diagnosed with the condition. While most have mild or moderate forms of the disease, 6 percent to...MacularProtect Complete® Powerful Protection for Macular & Full Body Health
Description:MacularProtect Complete® is a scientifically advanced nutritional formulation that provides powerful protection for macular and full body health. MacularProtect Complete is based on the AREDS clinical trial and other advanced research. It features a comprehensive multinutrient component that provides a broad foundation of antioxidants, such as 10 mg of FloraGLO® lutein, bioflavonoids, and...MacularProtect® Protection for Macular Health
Description:MacularProtect delivers levels of nutrients found to help preserve vision and macular health in the AREDS clinical trial, supported by The National Eye Institute. MacularProtect also delivers 10 mg of lutein, an antioxidant found to play an important role in eye health in other advanced research....MacularProtect Complete®-S Powerful Protection for Macular & Full Body Health
Description:MacularProtectComplete®-S is a scientifically advanced nutritional formulation that provides powerful protection for macular and full body health. MacularProtect Complete-S, based on the AREDS clinical trial and other advanced research, delivers a diverse array of antioxidants, such as 10 mg of FloraGLO® lutein and other important nutrients. It is free of beta-carotene and intended for in...Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
TARRYTOWN, N.Y. & LEVERKUSEN, Germany--(BUSINESS WIRE)--Mar 27,2007 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and BayerHealthCare AG (NYSE: BAY) today announced positive preliminary datafrom a pre-planned interim analysis of a Phase 2 randomized studyof their VEGF Trap-Eye in patients with the neovascular form ofage-related macular degeneration (wet AMD). The VEGF Trap-Eye metits...